NOVAiCOS ImmunoTherapeutics is led by a team of professionals driven by passion and dedication to innovation and scientific research. We work together to develop groundbreaking solutions in the field of immunotherapy for bone health.
President of the Board of Directors, CEO & Managing Director
Pharmaceutical Chemist & Technologist, former Pharma Business Head (Novartis & GE Healthcare groups)
LinkedIn
Major Owner & Co-Founder, President of the Scientific Advisory Board
MD, PhD, Professor of Immunology – UniUPO
LinkedIn
Member of the Board of Directors, Chief Scientific Officer
Researcher, Surgical Sciences – UniTO
LinkedIn
CMC Development Expert
MM Pharma Consulting owner; former Formulation & CMC VP & Global Head at Roche, Merck Serono, J&J, Aptuit, Zambon, Patheon, Polyphor
Preclinical Development Head & R&D Leader
Head of Preclinical Pharmacology – former Farmitalia, Pharmacia
Investor Relations Officer & Technology Transfer Leader
Board Member Cathinvest & Metis Precision Medicine – former Mittel, SG, Intesa, IMI
Member of the Board of Directors, Chief Financial & ERC Officer
Former CFO – Novartis Group
LinkedIn
We are committed to maintaining the highest standards of scientific rigor, transparency and reliability at every stage of research and development. Every decision is guided by our responsibility toward patients, the scientific community and the environment.
We believe in the power of synergy and teamwork, valuing the diversity of skills and perspectives. We foster an inclusive environment based on mutual respect, professional growth and knowledge sharing to achieve common goals.
We collaborate with strategic partners to accelerate innovation and advance pioneering solutions in bone health.
BioIndustry Park
Università del Piemonte Orientale
Bridge 4 Pharma
BioPmed
GemForLab
MM Pharma ConsultingInvestors, clinicians, researchers and partners: write to us and our team will get back to you shortly.